patients with other complications or patients without any complication (p ! 0.05). Multivariable analysis revealed that both age and pulmonary fi brosis were independent predictors of oxygen desaturation. However, the majority of the patients (94%) did not require routine oxygen supplementation. Conclusion: Although FFB is safe and does not require oxygen supplementation in most cases, age over 80 years and pulmonary fi brosis are high risk factors for signifi cant oxygen desaturation during FFB.
Introduction
Fiber-optic fl exible bronchoscopy (FFB) is a safe and frequently performed procedure for the diagnosis and treatment of pulmonary disorders. However, hypoxemia has been shown to occur during FFB procedures. Hypoxemia can occur by several mechanisms including oversedation, suctioning during the procedure, which can remove oxygen or decrease lung volumes below functional residual capacity (FRC), and increased ventilation-perfusion mismatching by bronchospasm, bleeding, and instillation of fl uids. Hypoxemia is one of the most dangerous
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Bronchoscopy ؒ Oxygen desaturation ؒ Pulmonary fi brosis ؒ Interstitial pneumonia Abstract Background: Fiber-optic fl exible bronchoscopy (FFB) is a frequently performed procedure for the diagnosis and treatment of pulmonary disorders. However, hypoxemia occasionally occurs during FFB. Objectives: We attempted to examine the causes of arterial oxygen desaturation during FFB. Methods: We studied 336 patients who underwent FFB without intervention between June 1, 2001 and September 30, 2002. Arterial oxygen saturation (SpO 2 ) was continuously monitored using oximetry with a recording system. We analyzed the relationship between a reduction in SpO 2 during FFB and various clinical parameters or background lung diseases. Results: Of the 336 patients, 73 (22%) had an episode of oxygen desaturation (SpO 2 ! 90% over 10 s). Of patients over 80 years old, 55% had an episode of oxygen desaturation, which was signifi cantly higher than 27% observed in the patients of 80 and less than 80 years old (p ! 0.05). Patients with pulmonary fi brosis had a higher risk of desaturation (55%) compared to complications because it has the potential to cause cardiac arrhythmia [1] .
Since the pulse oximeter became commercially available, monitoring of oxygen saturation during procedures has become routine in most institutions. The British Thoracic Society recommends that patients should be monitored by oximetry and that oxygen supplementation should be administered as necessary to achieve an oxygen saturation of at least 90% to reduce the risk of signifi cant arrhythmias during the procedure and also in the postoperative recovery period.
Patients with complicating lung diseases such as asthma and chronic obstructive pulmonary disease (COPD) have increased risks of oxygen desaturation during FFB [2] . However, Jones and O'Driscoll [3] argued that the majority of patients, especially those with a forced expiratory volume in 1 s (FEV 1 ) above 1 liter, did not require routine oxygen supplementation.
In the present study, we evaluated the arterial oxygen saturation (SpO 2 ) of patients during the FFB procedure without interventions and analyzed the relationship between oxygen desaturation and spirometric parameters or complicating lung diseases.
Materials and Methods

Subjects and Study Design
At the Hokkaido University Hospital, 336 patients underwent screening FFB without intervention between June 1, 2001 and September 30, 2002. These patients were 231 men and 105 women with an average age of 62.1 years (range 18-87 years). Approximately 90% of these patients underwent FFB because of localized pulmonary lesions or hemoptysis. Of these 336 patients, 257 underwent a spirogram within 3 weeks before or after bronchoscopy. However, we excluded the pulmonary function test data of those patients who may have had their pulmonary function test data altered by the FFB procedure, such as those with bronchial asthma and atelectasis.
The data included slow vital capacity (VC), %VC, FEV 1 , FEV 1 / forced vital capacity (FVC), FRC, %FRC, diffusing capacity for carbon monoxide (DLCO), %DLCO, DLCO/alveolar volume (DLCO/VA), and %DLCO/VA.
Complicating lung diseases such as COPD [4, 5] , asthma, pulmonary fi brosis [6] [7] [8] , sarcoidosis, postlobectomy, atelectasis, and pneumoconiosis were also retrospectively reviewed from the patients' medical records.
COPD was diagnosed following the GOLD guideline [9] . The diagnosis of pulmonary fi brosis was based on chest computed tomography (CT) fi ndings, which were characterized by ground-glass opacities, linear interstitial opacities, coarse reticular-nodular shadows, and honeycombing. We used a multidetector CT scanner (Aquilion Multi 4-detector, Toshiba, Tokyo, Japan) for all CT examinations. Conventional whole lung CT images were acquired of 5-mm-thick sections. If complicating lung diseases were suspected from conventional CT images, high-resolution CT with 1.0-mmthick sections was performed for those lesions. The high-resolution CT parameters were as follows: 1.0-mm collimation, 135-149 kVp, 100 mA, rotation time 1.0 s.
The differential diagnoses included idiopathic pulmonary fi brosis, nonspecifi c interstitial pneumonia, idiopathic pulmonary fi brosis associated with collagen vascular disease, farmer's lung, and other idiopathic interstitial pneumonias. Sarcoidosis was diagnosed according to the ATS guidelines [10] .
Fiber-Optic Flexible Bronchoscopy
In our unit, supplemental oxygen is not routinely given to the patients undergoing FFB. If, however, there was a sustained fall in oxygen saturation during the procedure (i.e., ! 90% for 30 s or ! 80% immediately), supplemental oxygen was administered nasally at a fl ow rate between 2 and 5 liters/min to maintain SpO 2 1 90%. Lidocaine was given for local anesthesia to all patients. Pentazocine (15 mg) and atropine sulfate (0.5 mg) were administered intramuscularly. FFB procedures were performed by seven pulmonary fellows who each had more than 5 years of FFB training and who were directly supervised and assisted by the pulmonary faculty.
Monitoring of SpO 2 during FFB SpO 2 was continuously monitored using oximetry with a fi nger probe (PULSOX-5™; Konica Minolta Holdings, Tokyo, Japan). The data were recorded, stored, and later analyzed using PULSOX SpO 2 Analysis Version 2.0a™ software (Stowood Scientifi c Instruments, Oxford, UK). Total examination time, average SpO 2 , duration of SpO 2 ! 90%, duration of SpO 2 ! 80%, and minimum SpO 2 were measured. The total examination time was the period between the insertion of the bronchoscope and the end of the fl uoroscopic screening (not including transbronchial biopsy and bronchoalveolar lavage). Oxygen desaturation was defi ned to be present when SpO 2 ! 90% continued more than 10 s.
Statistical Analysis
All data were processed using standard statistical methods with StatView™ version 5.0 software (SAS Institute, Cary, N.C., USA). Results were presented as mean 8 standard deviation (SD). Two by two frequency tables and the Pearson correlation coeffi cient test were used to estimate the relationship between the values obtained in spirometry tests and SpO 2 . Logistic regression analysis was applied for multivariable analysis of risk factors for desaturation. A p value of ! 0.05 was regarded as signifi cant.
Results
All FFB examinations were performed without any complications. The average total time of screening FFB without intervention was 9.7 min. Of the 336 patients, 73 patients (22%) had an episode of desaturation (SpO 2 ! 90% over 10 s) during FFB procedures. Among them, 19 patients (6%) required oxygen supplementation.
First, we analyzed the association between percentages of SpO 2 ! 90% and age. Of the patients over 80 years old, 55% had an episode of SpO 2 ! 90% (compared to patients of 80 and less than 80 years old, 27%, p ! 0.05) and oxygen supplementation was required for 18% of patients over 80 years old (compared to patients of 80 and less than 80 years old, 5%, p = 0.067). However, there were no statistical relationships between oxygen desaturation and various clinical parameters [height, weight, body mass index (BMI), VC, %VC, FEV 1 , FEV 1 /FVC, FRC, %FRC, DLCO, %DLCO, DLCO/VA, and %DLCO/VA]. Patients with a FEV 1 ^ 1.0 liter had a higher risk of oxygen desaturation compared to those with a FEV 1 1 1.0 liter, but the difference was not signifi cant (50 vs. 24%, p = 0.056). There was no signifi cant relationship between oxygen desaturation and SpO 2 at rest.
We next examined the association between oxygen desaturation and the presence of complicating lung disease ( table 1 ) . Among several complicating lung disorders, pulmonary fi brosis was the highest risk factor for oxygen desaturation. Of the patients with pulmonary fi brosis, 55% had an episode of oxygen desaturation, signifi cantly higher than patients with other complicating lung diseases or no complications (p ! 0.05). There were no signifi cant differences in age, FEV 1 , or other various clinical parameters (height, weight, BMI, VC, %VC, FEV 1 /FVC, FRC, %FRC, DLCO, %DLCO, DLCO/VA, and %DLCO/VA) between patients with pulmonary fi brosis and other patients. However, elderly patients with pulmonary fi brosis seemed to have a higher risk of oxygen desaturation. Among 4 patients over 75 years old with pulmonary fi brosis, 3 had an episode of oxygen desaturation ( table 2 ) . The 4th patient, who was 81 years old, had an episode of oxygen desaturation for a total of 280 s during FFB and needed oxygen supplementation.
Multivariate analysis revealed that age (over 80 years old) and the presence of pulmonary fi brosis were independent predictors of oxygen desaturation ( table 3 ) .
Discussion
In the present study, we analyzed the relationship between oxygen desaturation during FFB and various clinical parameters or complicating lung diseases. As a result, age and pulmonary fi brosis were identifi ed as signifi cant risk factors of oxygen desaturation. Although the number of patients might be small, this is the fi rst report to suggest an association between pulmonary fi brosis and oxygen desaturation during FFB.
As one of the mechanisms accounting for hypoxemia in patients with pulmonary fi brosis, low FRC should be considered. However, in the present study, there was no signifi cant difference between the level of FRC in patients with pulmonary fi brosis and that of the other patients (data not shown). On the other hand, it was reported that FRC increased during the FFB examination by the augmentation of airway resistance from FFB insertion [11] . Moreover, it was speculated that increased FRC maintained airway patency and prevented decreases in SpO 2 . However, FRC might not increase in the case of pulmonary fi brosis compared to other complicating diseases because of low lung compliance by the fi brosis, although we did not examine FRC during FFB in the present study. The British Thoracic Society guidelines recommend checking the spirometric parameters of patients with suspected COPD before FFB, and if the COPD is found to be severe (FEV 1 ! 40% or SpO 2 ! 93%), the patients should have arterial blood gas tensions measured. Oxygen supplementation may lead to an increase in the arterial PCO 2 level; in cases in which the prebronchoscopy arterial PCO 2 is raised, oxygen supplementation should be given with extreme caution. Other conditions that may complicate FFB are asthma, advanced patient age, a history of myocardial infarction, raised intracranial pressure, and hemoptysis [2] . However, pulmonary fibrosis has not been proposed as a high-risk disease of oxygen desaturation during FFB procedures. The precise reason is not clear; perhaps it is due to the diffi culty in diagnosing pulmonary fi brosis. Pulmonary fi brosis includes a wide spectrum of pulmonary abnormalities and infl ammatory diseases of the pulmonary interstitium. In this study, when we defi ned pulmonary fi brosis only from chest CT fi ndings, the relationship between oxygen desaturation during FFB and pulmonary fi brosis emerged.
A number of studies have shown a high incidence of lung cancer in patients with idiopathic pulmonary fi brosis compared to control subjects [12, 13] . Patients with pulmonary fi brosis should frequently receive FFB and, thus, should receive closer attention regarding oxygen desaturation during FFB. 
